Literature DB >> 12137837

Posterior urethral valves: does young age at diagnosis correlate with poor renal function?

M T El-Sherbiny1, A T Hafez, A A Shokeir.   

Abstract

OBJECTIVES: To determine whether young age at presentation is associated with poor renal function in patients with posterior urethral valves (PUVs). Previous studies have indicated that a young age at diagnosis is an adverse prognostic factor for patients with PUVs.
METHODS: Fifty-three children with PUVs were diagnosed between January 1998 and March 2000. The patients included 25 infants with a median age of 3 months (group 1) and 28 children with a median age of 3.5 years (group 2). No statistically significant difference was present between the two groups regarding presenting symptoms, incidence of hydronephrosis, bilateral vesicoureteral reflux, presence of popoff mechanisms, or number of positive urinary cultures at presentation. Primary valve ablation was carried out in all patients. The median follow-up period for groups 1 and 2 was 19 and 18.5 months, respectively (P <0.05).
RESULTS: The percentage of serum creatinine deviation greater than the normal age-reference range was calculated for each patient at diagnosis and at the last follow-up visit. The median percentage of serum creatinine deviation at presentation was 190% for group 1 and 22% for group 2 (P >0.05). The median percentage of serum creatinine deviation at the last follow-up visit was nil for group 1 and 10% for group 2 (P <0.009). Persistently dilated upper tracts were noted in 48% and 86% of patients in groups 1 and 2, respectively (P <0.004).
CONCLUSIONS: In contrast to the findings of previous studies, we provide evidence of a less favorable outcome with delayed presentation of PUVs relative to those diagnosed in the first year after birth in respect to renal function and upper tract dilation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12137837     DOI: 10.1016/s0090-4295(02)01821-6

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Validation of initial serum creatinine as a predictive factor for development of end stage renal disease in posterior urethral valves.

Authors:  Azar Nickavar; Hassan Otoukesh; Kambiz Sotoudeh
Journal:  Indian J Pediatr       Date:  2008-06-21       Impact factor: 1.967

2.  Which patients are at higher risk for residual valves after posterior urethral valve ablation?

Authors:  Mehdi Shirazi; Mohamadreza Farsiani; Mohammad Natami; Kiomars Izadpanah; Amir Malekahmadi; Abbasali Khakbaz
Journal:  Korean J Urol       Date:  2014-01-15

Review 3.  Predicting and Modifying Risk for Development of Renal Failure in Boys with Posterior Urethral Valves.

Authors:  Christopher J Long; Diana K Bowen
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

4.  Outcome of late presentation of posterior urethral valves in a resource-limited economy: challenges in management.

Authors:  Odutola Israel Odetunde; Oluwatoyin Arinola Odetunde; Adesoji Oludotun Ademuyiwa; Henrietta Uche Okafor; Uchenna Ekwochi; Jonathan Chukwuemeka Azubuike; Nene Elsie Obianyo
Journal:  Int J Nephrol       Date:  2012-09-19

5.  Study of prognostic significance of antenatal ultrasonography and renin angiotensin system activation in predicting disease severity in posterior urethral valves.

Authors:  Divya Bhadoo; M Bajpai; Ali Abid; Gayan Sukanya; Sandeep Agarwala; M Srinivas; Deepika Deka; Nutan Agarwal; Ramesh Agarwal; Rakesh Kumar
Journal:  J Indian Assoc Pediatr Surg       Date:  2015 Apr-Jun

6.  Posterior urethral valve: Prognostic factors and renal outcome.

Authors:  Divya Bhadoo; Minu Bajpai; Shasanka Shekhar Panda
Journal:  J Indian Assoc Pediatr Surg       Date:  2014-07

7.  Short-Term Outcomes of Treatment of Boys with Posterior Urethral Valves.

Authors:  Abdulrasheed A Nasir; Adewale O Oyinloye; Lukman O Abdur-Rahman; Kayode T Bamigbola; Nurudeen T Abdulraheem; Olanrewaju T Adedoyin; James O Adeniran
Journal:  Niger Med J       Date:  2020-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.